ES2546861T3 - Envase tipo blíster - Google Patents

Envase tipo blíster Download PDF

Info

Publication number
ES2546861T3
ES2546861T3 ES06831450.9T ES06831450T ES2546861T3 ES 2546861 T3 ES2546861 T3 ES 2546861T3 ES 06831450 T ES06831450 T ES 06831450T ES 2546861 T3 ES2546861 T3 ES 2546861T3
Authority
ES
Spain
Prior art keywords
tablets
blister pack
layer
pvc
foil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES06831450.9T
Other languages
English (en)
Inventor
Graham Cairns
Neil Hyde
Andrew Knowles
Kerry Anne Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alliance Pharmaceuticals Ltd
Original Assignee
Alliance Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alliance Pharmaceuticals Ltd filed Critical Alliance Pharmaceuticals Ltd
Application granted granted Critical
Publication of ES2546861T3 publication Critical patent/ES2546861T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A61J1/035Blister-type containers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Packages (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Wrappers (AREA)

Abstract

Un envase tipo blíster, que contiene comprimidos medicinales, formado de un material metálico, que comprende una parte basal que contiene cavidades para los comprimidos formada de una lámina formada en frío que comprende una capa metálica laminada sobre una capa de PVC, siendo la capa de PVC la superficie de contacto con el producto sobre la cual hay colocada una lámina metálica que el comprimido puede romper, en donde los comprimidos comprenden de 3 a 10 mg de maleato de proclorperazina y en donde los comprimidos del envase están protegidos contra los daños por agua.

Description

imagen1
imagen2
imagen3

Claims (1)

  1. imagen1
ES06831450.9T 2006-01-04 2006-12-22 Envase tipo blíster Active ES2546861T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0600075 2006-01-04
GB0600075A GB2433887A (en) 2006-01-04 2006-01-04 Pack for phenothiazine derivatives
PCT/GB2006/004891 WO2007077421A1 (en) 2006-01-04 2006-12-22 Pack

Publications (1)

Publication Number Publication Date
ES2546861T3 true ES2546861T3 (es) 2015-09-29

Family

ID=35911363

Family Applications (1)

Application Number Title Priority Date Filing Date
ES06831450.9T Active ES2546861T3 (es) 2006-01-04 2006-12-22 Envase tipo blíster

Country Status (10)

Country Link
US (1) US20080023365A1 (es)
EP (1) EP1968552B1 (es)
CN (1) CN101351194A (es)
AU (1) AU2006334243B2 (es)
CA (1) CA2636210A1 (es)
ES (1) ES2546861T3 (es)
GB (1) GB2433887A (es)
NZ (1) NZ569218A (es)
WO (1) WO2007077421A1 (es)
ZA (1) ZA200805275B (es)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5226537B2 (es) * 1973-08-07 1977-07-14
US4573581A (en) * 1983-07-18 1986-03-04 Network Medical Containers Pty, Ltd. Environmentally controlled medication container
GB8426152D0 (en) * 1984-10-16 1984-11-21 Reckitt & Colmann Prod Ltd Medicinal compositions
US4612755A (en) * 1985-07-24 1986-09-23 Minnesota Mining And Manufacturing Company Blister pack laminating device and method
US5046618A (en) * 1990-11-19 1991-09-10 R. P. Scherer Corporation Child-resistant blister pack
WO1994008873A1 (en) * 1992-10-08 1994-04-28 Habley Medical Technology Corporation Blister pack pill dispenser
CH689305A5 (de) * 1994-08-23 1999-02-15 Alusuisse Lonza Services Ag Blisterpackung.
EP0905042A1 (de) * 1997-09-17 1999-03-31 Alusuisse Technology & Management AG Blister- oder Durchdrückpackung
DE19931364A1 (de) * 1999-07-07 2001-01-18 Lohmann Therapie Syst Lts Blisterkartonverpackung für empfindliches Packgut mit leichtflüchtigen und/oder feuchtigkeitsempfindlichen Komponenten
GB2371983A (en) * 2001-02-12 2002-08-14 Reckitt & Colmann Prod Ltd Compositions to treat irritable bowel syndrome
GB0108930D0 (en) * 2001-04-10 2001-05-30 Boots Co Plc Therapeutic agents
US20030203141A1 (en) * 2002-04-25 2003-10-30 Blum John B. Blister package
GB0225621D0 (en) * 2002-11-02 2002-12-11 Glaxo Group Ltd Medicament carrier
EP1468935A1 (de) * 2003-04-16 2004-10-20 Alcan Technology & Management Ltd. Blisterverpackung
US7758936B2 (en) * 2003-09-18 2010-07-20 Boehringer Ingelheim Gmbh Pharmaceutical blister

Also Published As

Publication number Publication date
EP1968552A1 (en) 2008-09-17
CA2636210A1 (en) 2007-07-12
CN101351194A (zh) 2009-01-21
NZ569218A (en) 2011-05-27
GB2433887A (en) 2007-07-11
WO2007077421A1 (en) 2007-07-12
ZA200805275B (en) 2009-09-30
GB0600075D0 (en) 2006-02-15
AU2006334243B2 (en) 2012-03-29
EP1968552B1 (en) 2015-07-22
US20080023365A1 (en) 2008-01-31
AU2006334243A1 (en) 2007-07-12

Similar Documents

Publication Publication Date Title
AR065809A1 (es) Formulaciones farmaceuticas que contienen un inhibidor sglt2
ES2269649T3 (es) Paquete de blisters de cuello constreñido y aparato y metodo para su fabricacion.
PE20051127A1 (es) Comprimido multicapa de telmisartan y ramipril
CR11625A (es) Formulacion de capsula
ES2582779T3 (es) Forma de dosificación oral de acetaminofeno/tramadol de liberación prolongada
CU23440B7 (es) Composición de liberación sostenida de pramipexol
WO2007073702A3 (es) Comprimido multicapa con combinación de triple liberación
CL2008003615A1 (es) Composicion farmaceutica transmucosal oral que comprende fenilefrina, o una sal de ella, que esta en forma de tiras, de capa bioadhesiva, de liquido para pulverizar, de pastilla , de gel, de capsulas o de tableta; dispositivo portador.
BRPI0509971A (pt) uma forma de dosagem farmacêutica, comprimido e método de preparação
ATE345989T1 (de) Blisterpackung für inhalierbares arzneimittel
DK1441790T3 (da) Pakning, der indeholder medikament, og dispenserindretning
ECSP099629A (es) Composición farmacéutica
DOP2012000217A (es) Pastillas de gelatina blanda con nicotina
EA200801926A1 (ru) Таблетки парацетамола с быстрым высвобождением
CO5590906A2 (es) Composiciones farmaceuticas que comprenden metformina y glibenclamida para el tratamiento de la diabetes mellitus tipo ii
WO2011101866A3 (en) Gastric retention formulation containing baclofen
AR075369A1 (es) Comprimidos para terapia de combinacion para el tratamiento de infecciones virales.
NI201200028A (es) Paquete unitario y método para formar el mismo
AR068985A1 (es) Envase 043
ES2546861T3 (es) Envase tipo blíster
CO6251231A2 (es) Dispositivo y uso para conservar y poner a disposicion aobleas de medicamento
ZA200701443B (en) Pharmaceutical composition in the form of a gastric-resident tablet containing an active principle
PE20120956A1 (es) Composicion farmaceutica que contiene buprenorfina y nalmefeno
CO6150129A2 (es) Formas segmentadas de dosificacion farmaceutica
AR070256A1 (es) Lata, en particular para envasar productos alimenticios, con lacado interior parcial